Samuel Bjork
InvestorPartner at Digitalis Ventures
Brooklyn, New York
Writes $100K – $10M checks · typically $1.5M
About
Samuel Bjork is a Marshall Scholar with Harvard, Cambridge and Oxford backgrounds who pairs therapeutics investing with e-commerce, reflecting an engineering-health focus at the life-sciences and digital health/pet services intersection.
Invests in
AI & Machine LearningBiotechDeep TechDigital HealthHardwareHealthtechMedical Devices
Investments
Board seats
Bonum TherapeuticsElemental MachinesEpiBiologicsGood TherapeuticsJudo BioNuvig TherapeuticsPetMedixProtegoScoutBioSeQure DxSwitch TherapeuticsT-TherapeuticsTerray Therapeutics
Per the firm's website.
Colleagues at Digitalis Ventures
Amit Bansal
Partner at Digitalis Ventures
Ben Jacobs
Partner at Digitalis Ventures
Bo Stewart
Associate at Digitalis Ventures
Charles K. Herman
Venture Partner at Digitalis Ventures
Cindy Cole
Technical Partner at Digitalis Ventures
Dac Nguyen
Technical Partner at Digitalis Ventures
Drew Taylor
Partner at Digitalis Ventures
Dylan Henderson
Accounting Manager at Digitalis Ventures